Ratings by Canaccord (Robert Young)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | Sangoma Technologies Corp | SANG | Downgrade | Hold (Spec. Buy) |
4.09 (3.72) |
-9.05% | Details | |
| 3/2/2026 | Docebo Inc. | DCBO | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Docebo Inc. | DCBO | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Docebo Inc. | DCBO | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Descartes | DSGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | Sangoma Technologies Corp | SANG | Upgrade | Spec. Buy (Hold) |
2.87 (4.09) |
42.51% | Details | |
| 12/6/2023 | Descartes | DSGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Sangoma Technologies Corp | SANG | Downgrade | Hold (Buy) |
3.03 (3.72) |
22.77% | Details | |
| 3/10/2023 | Docebo Inc. | DCBO | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2022 | Celestica | CLS | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2022 | Sangoma Technologies Corp | SANG | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2022 | Descartes | DSGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Docebo Inc. | DCBO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2022 | Celestica | CLS | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2021 | Descartes | DSGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Descartes | DSGX | Maintain | Buy (Buy) |
|
Details | ||
| 1/30/2020 | Celestica | CLS | Maintain | Hold (N/A) |
|
Details | ||
| 4/26/2019 | Celestica | CLS | Downgrade | Hold (Buy) |
8.61 (362.24) |
4107.2% | Details |
